Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

What is THC's Net Revenue (Sales)?

  Tenet Healthcare Corp ( THC ) |
1985 - 2021 (37 years)

Net Revenue (Sales) is 
$18.6B (1Y +3.26% )

THC Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for THC competitors.
LPNT FMS UHS CYH DVA SEM MD SSY HCA
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $9.4B +4.6x
( +4.8% / year avg)
chevron_left 1985 $1.7B
vertical_align_top Peak $21.7B +14.7x
vertical_align_bottom Bottom $1.4B
arrow_drop_up # Up Years 20 20 of 37
years up.
arrow_drop_down # Down Years 17
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • THC's stock price has drop +35.7% from $20.9 in 1985 , or -0.14x the rate relative to it's net revenue (sales) over the same period.
  • If THC grows it's stock at the same rate as it's net revenue (sales) (+4.8%/year) , it's stock price will grow +159% and hit $45.32 over the next 10 years.
  • THC's stock price has gone up 11 of the 20 years (+55%) it's net revenue (sales) were also up.
  • THC Historical Net Revenue (Sales) Table
    in $ million
    Year Net Revenue (Sales) YoY % Change Stock Price YoY % Change (Stock Price)
    4/1/2021 $9,450 -46.1% $28.36 30.3%
    4/1/2020 $17,531 -4.2% $21.76 9.0%
    4/1/2019 $18,292 -2.0% $19.96 -43.7%
    4/1/2018 $18,672 -2.0% $35.43 114.2%
    4/1/2017 $19,061 -3.7% $16.54 -42.8%
    4/1/2016 $19,787 9.4% $28.94 -45.6%
    4/1/2015 $18,080 12.8% $53.19 13.2%
    4/1/2014 $16,032 67.9% $47.0 -0.8%
    4/1/2013 $9,548 12.8% $47.37 151.4%
    4/1/2012 $8,468 -11.1% $18.84 -26.2%
    4/1/2011 $9,523 3.9% $25.52 11.5%
    4/1/2010 $9,165 2.2% $22.88 57.6%
    4/1/2009 $8,965 0.0% $14.52 -38.5%
    4/1/2008 $8,964 0.7% $23.6 -15.1%
    4/1/2007 $8,898 -1.5% $27.8 -12.2%
    4/1/2006 $9,033 -6.7% $31.68 -34.7%
    4/1/2005 $9,682 -10.0% $48.48 1.7%
    4/1/2004 $10,763 -50.4% $47.68 -28.6%
    4/1/2003 $21,679 51.4% $66.76 -41.9%
    4/1/2002 $14,319 14.9% $115.0 -25.0%
    4/1/2001 $12,457 43.9% $153.39 46.3%
    4/1/2000 $8,654 -38.1% $104.83 102.3%
    4/1/1999 $13,988 82.1% $51.81 -26.0%
    4/1/1998 $7,680 -29.1% $69.97 -14.1%
    4/1/1997 $10,824 89.4% $81.46 46.4%
    4/1/1996 $5,713 23.1% $55.64 16.8%
    4/1/1995 $4,640 235.5% $47.64 15.3%
    4/1/1994 $1,383 -61.1% $41.31 61.0%
    4/1/1993 $3,551 -7.7% $25.65 -10.4%
    4/1/1992 $3,849 -3.1% $28.64 -46.0%
    4/1/1991 $3,972 6.2% $53.07 29.9%
    4/1/1990 $3,741 -5.6% $40.86 1.5%
    4/1/1989 $3,963 15.4% $40.25 69.7%
    4/1/1988 $3,432 26.4% $23.72 -16.0%
    4/1/1987 $2,715 -30.9% $28.25 12.9%
    4/1/1986 $3,931 134.4% $25.03 12.4%
    4/1/1985 $1,677 - $22.27 -

  • About
    Industry: Medical Care Facilities
    Sector: Healthcare
    Country: US
    IPO Date: 5/22/1981
    Stonk Exchange: NYSE
    • Tenet Healthcare Corp
    • engages in the provision of health care services.
    • The company is headquartered in Dallas, Texas and currently employs 90,090 full-time employees.
    • The firm operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States.
    • The firm's segments include Hospital Operations and Other, Ambulatory Care and Conifer.
    • As of December 31, 2017, its subsidiaries operated 76 hospitals, including two children's hospitals, two specialty hospitals and one critical access hospital.
    • The firm's Ambulatory Care segment is engaged in the operations of its USPI joint venture facilities.
    • As of August 20, 2018, Conifer provided one or more of the business process services described above from 20 service centers to more than 800 Tenet and non-Tenet hospital and other clients in over 40 states.
    • As of December 31, 2017, the Company operated 20 short-stay surgical hospitals, and over 470 outpatient centers.

  • "The Top Line"

    The revenue (or sales) is the value of a company's sales of goods and services to its customers. Although a company's bottom line (its net income) gets most of the attention from investors, the top line is where the revenue or income process begins. Also, in the long run, profit margins on a company's existing products tend to eventually reach a maximum that is difficult to improve. Thus, companies typically can grow no faster than their revenues.

    For more detailed definitions, please see Investopedia.